The financial world continually evolves,
embracing innovation and complexity and
absorbing the new regulation. As the pace
of change increases, we work to help
clients overcome the challenges and
benefit from the opportunities.
The list of new products and new
regulations keeps growing – from
segregated collateral arrangements, to
increasingly complex structured repos, to
the implementation of the many strands of
the European Markets Infrastructure
Regulation – and our role is to help you
integrate these successfully into your
existing business streams and to maximize
their potential for you.
We cover all types of asset classes – Forex, TOI's, bonds,
cryptocurrency , plastic blockchain, hemp blockchain,
cannabis stock and commodities and in addition to OTC
derivatives, we advise on lucrative market research and
investment.
We have been active in asset management industry for a
couple of years, giving our dedicated team of expert traders
and managers true depth of experience. Our flexibility and
knowledge of this area means that we can meet your needs –
however demanding, complex and time-critical.
No industry is more inventive – or more highly regulated –
than the financial services industry. So a good asset
management company in this field needs to be quick
thinking. Our financial services team is equipped to provide
advice in this fast-changing and fluid market.
Our knowledge of the financial sector is both broad and deep
because our clients come from a range of financial services
industries, encompassing investment management,
insurance and pensions, real estate and retirement, as well as
new services such as trading platforms, crowd funding
enablers, e-money and payment services.
With regulators now focused on outcomes-based regulation,
and with traditionally separate markets and products lines
converging and overlapping, it is vital for traders and
managers to have this breadth and depth of understanding.
On the contentious side, we act for investors looking for
financial services advice.
Delta-9 tetrahydrocannabinol
(THC) is the primary psychoactive ingredient in marijuana. Cannabidiol (CBD) is
another important cannabinoid that has been found to possess therapeutic
benefits.
These two ingredients have been at the forefront of a battle over marijuana. The
United States, along with many other countries around the world, prohibit the
use of marijuana at the federal level, primarily because of the mind-altering
effects and potentially addictive attributes of THC. However, the potential
therapeutic benefits of CBD have led 30 U.S. states and countries, including
Canada and Germany, to legalize medical marijuana. In addition, nine U.S.
states and the District of Columbia also now allow the legal recreational use of
marijuana. Canada's recreational cannabis market is scheduled to open on Oct.
17, 2018.
Although marijuana legalization is still somewhat controversial, public support
for legalization in the U.S. and other countries has continued to increase. For
example, a recent survey from the Center for American Progress, a progressive
public policy research and advocacy group, found that 68% of Americans
support legalizing marijuana -- a record high level of support. Forty percent of
respondents strongly support legalization of the drug.
The spread of marijuana legalization has created a blossoming industry.
Businesses have popped up to service every part of the growing industry, from
cultivating and growing cannabis (or providing services to the growers), to
distribution and retail marketing, and even to biotech development of
cannabinoid-based prescription drugs.
You've no doubt seen firsthand the impressive growth in public support
for marijuana, as evidenced by the growing number of states that have
legalized the drug for medical or recreational purposes. You've probably
heard about the enormous gains marijuana stocks have generated over
the past couple of years. You might also be aware of predictions about
how large the marijuana industry could become, including a recent
projection that the U.S. marijuana market could reach $22 billion by 2022.
If all of these developments have you contemplating the idea of investing
in marijuana stocks, you're not alone. Increasing numbers of investors have
bought shares of marijuana stocks in anticipation of making huge returns.
But should you invest in marijuana stocks? Here's what you need to know
to make an informed decision.
Many companies in the cannabis industry have opted to "go public,"
making their shares available for purchase on public stock markets, to
raise cash to fuel additional growth. This growth potential is the most
compelling reason to consider investing in marijuana stocks.
Canada's vote to legalize recreational marijuana has lent significant
investor attention to Canadian marijuana stocks. Arcview Market Research
and BDS Analytics project that Canadian marijuana sales will jump from
around $600 million last year to $5.4 billion by 2022. That's a compound
annual growth rate of more than 55%.
Germany legalized medical marijuana in 2017. The country's cannabis
market could approach $1.6 billion by 2022, according to Arcview and BDS
Analytics, up from only around $9 million last year. This projected growth
makes Germany not only the biggest international marijuana market
outside of North America but also the fastest-growing marijuana market in
the world. But the biggest prize of all is still the United States. Even with
the rapid expansion of marijuana markets in Canada, Germany, and
elsewhere, the U.S. still is likely to account for close to three-quarters of
total cannabis revenue four years from now.
Overall, there is a possibility that the global marijuana market will more
than triple from 2018 to the end of 2022. There will probably be several big
winners from this sizzling growth. Investors who accurately pick those
winners should be set for some fantastic returns over the next few years.
We are committed to making investors addicted with our systems. the crux
of the program is to keep investors coming back for more and we can only
do that by satisfying them impeccably.
We have an extensive experience with finance and its dynamics and we
have come with pot stocks to better satisfy our clients. There are several
reasons to work with us and they include: